Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.460
-0.150 (-5.75%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Xenetic Biosciences Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Xenetic Biosciences.

Analyst Consensus: Hold
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

According to 1 stock analyst, the rating for Xenetic Biosciences is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 000000
Buy 000000
Hold 111111
Sell 000000
Strong Sell 000000
Total 111111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
Hold Reiterates n/a n/a Mar 20, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
Hold Reiterates n/a n/a Dec 5, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
Hold Reiterates n/a n/a Nov 22, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
Hold Reiterates n/a n/a Aug 20, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
Hold Downgrades n/a n/a May 16, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
1.84M
from 2.50M
Decreased by -26.57%
Revenue Next Year
2.35M
from 1.84M
Increased by 27.78%
EPS This Year
-3.30
from -2.57
EPS Next Year
-0.46
from -3.30
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
436.94K1.16M1.71M2.54M2.50M1.84M2.35M-
Revenue Growth
2,460.31%165.64%47.06%48.81%-1.56%-26.57%27.78%-
EPS
-17.04-5.49-4.61-2.71-2.57-3.30-0.46-0.55
EPS Growth
--------
Forward PE
--------
No. Analysts -----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026
High 1.9M 2.4M
Avg 1.8M 2.3M
Low 1.8M 2.3M

Revenue Growth

Revenue Growth 20252026
High
-24.4%
31.5%
Avg
-26.6%
27.8%
Low
-29.4%
22.8%

EPS Forecast

EPS 202520262027
High -3.40 -0.47 -0.57
Avg -3.30 -0.46 -0.55
Low -3.18 -0.44 -0.53

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.